These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6796907)

  • 1. Hyperammonemia and asterixis with valproic acid.
    Coulter D
    Neurology; 1981 Dec; 31(12):1580. PubMed ID: 6796907
    [No Abstract]   [Full Text] [Related]  

  • 2. [Encephalopathy with asterixis induced by sodium valproate. Role of hyperammonemia without hepatic insufficiency].
    Gastaut JL; Mege JL
    Presse Med; 1985 Feb; 14(7):431. PubMed ID: 3157141
    [No Abstract]   [Full Text] [Related]  

  • 3. Asterixis associated with sodium valproate.
    Bodensteiner JB; Morris HH; Golden GS
    Neurology; 1981 Feb; 31(2):194-5. PubMed ID: 6780925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperammonemia secondary to valproic acid as a cause of lethargy in a postictal patient.
    Kulick SK; Kramer DA
    Ann Emerg Med; 1993 Mar; 22(3):610-2. PubMed ID: 8192712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymptomatic hyperammonemia in patients receiving valproic acid.
    Murphy JV; Marquardt K
    Arch Neurol; 1982 Sep; 39(9):591-2. PubMed ID: 6810855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid and secondary hyperammonemia.
    Rawat S; Borkowski WJ; Swick HM
    Neurology; 1981 Sep; 31(9):1173-4. PubMed ID: 6791053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperammonemia with valproic acid therapy.
    Coulter DL; Allen RJ
    J Pediatr; 1981 Aug; 99(2):317-9. PubMed ID: 6788925
    [No Abstract]   [Full Text] [Related]  

  • 8. Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman.
    Mallet L; Babin S; Morais JA
    Ann Pharmacother; 2004 Oct; 38(10):1643-7. PubMed ID: 15316109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nondosage-dependent valproic acid-induced hyperammonemia and coma.
    Gaskins JD; Holt RJ; Postelnick M
    Clin Pharm; 1984; 3(3):313-6. PubMed ID: 6428801
    [No Abstract]   [Full Text] [Related]  

  • 10. Carnitine for valproic acid-induced hyperammonemia.
    Raby WN
    Am J Psychiatry; 1997 Aug; 154(8):1168-9. PubMed ID: 9247410
    [No Abstract]   [Full Text] [Related]  

  • 11. Valproic acid-induced hyperammonemia in mentally retarded adults.
    Williams CA; Tiefenbach S; McReynolds JW
    Neurology; 1984 Apr; 34(4):550-3. PubMed ID: 6422325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardization in VPA-induced hyperammonemia.
    Zaret BS; Marini AM
    Neurology; 1985 Jan; 35(1):136-7. PubMed ID: 3917561
    [No Abstract]   [Full Text] [Related]  

  • 13. [Metabolic encephalopathy can be a potentially life-threatening complication from valproic acid].
    Meinardi MC; van den Berg GB; Groenhuijzen A; Driessen JT; Maas HA; Wolfhagen FH
    Ned Tijdschr Geneeskd; 2008 Feb; 152(5):278-82. PubMed ID: 18333544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymptomatic hyperammonemia in children treated with valproic acid.
    Altunbaşak S; Baytok V; Tasouji M; Hergüner O; Burgut R; Kayrin L
    J Child Neurol; 1997 Oct; 12(7):461-3. PubMed ID: 9373804
    [No Abstract]   [Full Text] [Related]  

  • 15. A mechanism for valproate-induced hyperammonemia.
    Coude FX; Rabier D; Cathelineau L; Grimber G; Parvy P; Kamoun PP
    Pediatr Res; 1981 Jun; 15(6):974-5. PubMed ID: 6787550
    [No Abstract]   [Full Text] [Related]  

  • 16. [Isolated hyperammonemia. A frequent consequence of treatment with sodium valproate].
    Warter JM; Marescaux C; Rumbach L; Galmiche J; Micheletti G; Koehl C; Imler M
    Nouv Presse Med; 1981 Nov; 10(41):3406-7. PubMed ID: 6795590
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sodium valproate, hyperammonemia and hepatic encephalopathy].
    Imler M; Warter JM; Marescaux C
    Gastroenterol Clin Biol; 1982 Dec; 6(12):1042. PubMed ID: 6819177
    [No Abstract]   [Full Text] [Related]  

  • 18. [Carglumic acid for treatment of valproic acid-induced hyperammonaemia in a paediatric patient].
    Gramage Caro T; Vélez-Díaz-Pallarés M; Serna Pérez J; Bermejo Vicedo T
    Farm Hosp; 2012; 36(5):437-8. PubMed ID: 22858088
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of glutamine synthetase gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy.
    Inoue K; Takahashi T; Yamamoto Y; Suzuki E; Takahashi Y; Imai K; Inoue Y; Hirai K; Tsuji D; Itoh K
    Seizure; 2015 Dec; 33():76-80. PubMed ID: 26599579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperammonemia and valproate-induced alterations of the state of consciousness. A report of 8 cases.
    Zaccara G; Paganini M; Campostrini R; Arnetoli G; Zappoli R; Moroni F
    Eur Neurol; 1984; 23(2):104-12. PubMed ID: 6426961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.